## BACKGROUND. Because malignant transformation of dysplastic oral leukoplakia has been reported in up to 43% of cases, these lesions must be managed. ## METHODS. This study evaluated the use of topical 1% bleomycin in dimethylsulfoxide for the treatment of dysplastic oral lesions. Bleomycin wa
Treatment of recurrent paget's disease of the vulva with topical bleomycin
β Scribed by Watson G. Watring; James A. Roberts; Leo D. Lagasse; Michael L. Berman; Samuel C. Ballon; J. George Moore; Roger E. Schlesinger
- Publisher
- John Wiley and Sons
- Year
- 1978
- Tongue
- English
- Weight
- 169 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## RESULTS. The median follow-up for surviving patients was 62 months. Three pa- ## Michigan. tients (10%) developed a recurrence in the breast as the only site of first failure,
Eighteen patients with advanced Hodgkin's disease, refractory to combination chemotherapy with nitrogen mustard, vincristine, prednisone, and procarbazine (MOPP), were treated with vinblastine, doxorubicin (Adriamycin), bleomycin, CCNU, and dacarbazine (DTIC) (VABCD). Fifteen patients had Stage IV d
twenty-seven patients with advanced Hodgkin's disease who failed MOPP (nitrogen mustard, vincristine, procarbazine and prednisone) were treated with adriamycin, bleomycin, vinblastine, and imidazole carboxamide, (ABVD). Complete response (CR) was achieved in 22% of patients and partial response was